{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:48:04Z","timestamp":1784958484424,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00198-019-05206-0","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T10:01:31Z","timestamp":1574071291000},"page":"109-118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Proton pump inhibitors and fracture risk. The HUNT study, Norway"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9992-8663","authenticated-orcid":false,"given":"M.","family":"Hoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Skovlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Skurtveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Langhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Syversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Forsmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"5206_CR1","unstructured":"(2019) The Norwegian Prescription Database. The Norwegian Institute of Public Health. http:\/\/www.norpd.no\/"},{"key":"5206_CR2","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947\u20132953","journal-title":"JAMA"},{"key":"5206_CR3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 79:76\u201383","journal-title":"Calcif Tissue Int"},{"key":"5206_CR4","unstructured":"U.S. Food & Drug Administration F FDA. https:\/\/www.fda.gov\/drugs\/DrugSafety\/ucm199082.htm"},{"key":"5206_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","volume":"30","author":"TN Poly","year":"2019","unstructured":"Poly TN, Islam MM, Yang HC, Wu CC, Li YJ (2019) Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 30:103\u2013114","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"5206_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","volume":"27","author":"B Zhou","year":"2016","unstructured":"Zhou B, Huang Y, Li H, Sun W, Liu J (2016) Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27:339\u2013347","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"5206_CR7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/003655201750422585","volume":"36","author":"GL Cui","year":"2001","unstructured":"Cui GL, Syversen U, Zhao CM, Chen D, Waldum HL (2001) Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. Scandinavian journal of gastroenterology 36:1011\u20131015","journal-title":"Scandinavian journal of gastroenterology"},{"key":"5206_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcb.23337","volume":"113","author":"R Fossmark","year":"2012","unstructured":"Fossmark R, Stunes AK, Petzold C, Waldum HL, Rubert M, Lian AM, Reseland JE, Syversen U (2012) Decreased bone mineral density and reduced bone quality in H(+)\/K(+) ATPase beta-subunit deficient mice. J Cell Biochem 113:141\u2013147","journal-title":"J Cell Biochem"},{"key":"5206_CR9","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00296-013-2709-0","volume":"33","author":"K Ozdil","year":"2013","unstructured":"Ozdil K, Kahraman R, Sahin A, Calhan T, Gozden EH, Akyuz U, Erer B, Sokmen MH (2013) Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int 33:2255\u20132260","journal-title":"Rheumatol Int"},{"key":"5206_CR10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00774-015-0699-6","volume":"34","author":"E Bahtiri","year":"2016","unstructured":"Bahtiri E, Islami H, Hoxha R, Qorraj-Bytyqi H, Rexhepi S, Hoti K, Thaci K, Thaci S, Karakulak C (2016) Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors. Journal of bone and mineral metabolism 34:571\u2013579","journal-title":"Journal of bone and mineral metabolism"},{"key":"5206_CR11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","volume":"138","author":"LE Targownik","year":"2010","unstructured":"Targownik LE, Lix LM, Leung S, Leslie WD (2010) Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology 138:896\u2013904","journal-title":"Gastroenterology"},{"key":"5206_CR12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ajg.2012.200","volume":"107","author":"LE Targownik","year":"2012","unstructured":"Targownik LE, Leslie WD, Davison KS et al (2012) The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol 107:1361\u20131369","journal-title":"Am J Gastroenterol"},{"key":"5206_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jocd.2018.06.008","volume":"22","author":"YH Shin","year":"2019","unstructured":"Shin YH, Gong HS, Baek GH (2019) Lower trabecular bone score is associated with the use of proton pump inhibitors. Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 22:236\u2013242","journal-title":"Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry"},{"key":"5206_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ajg.2016.481","volume":"112","author":"LE Targownik","year":"2017","unstructured":"Targownik LE, Goertzen AL, Luo Y, Leslie WD (2017) Long-term proton pump inhibitor use is not associated with changes in bone strength and structure. Am J Gastroenterol 112:95\u2013101","journal-title":"Am J Gastroenterol"},{"key":"5206_CR15","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/jbmr.2279","volume":"29","author":"JR Lewis","year":"2014","unstructured":"Lewis JR, Barre D, Zhu K, Ivey KL, Lim EM, Hughes J, Prince RL (2014) Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 29:2489\u20132497","journal-title":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"},{"key":"5206_CR16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","volume":"118","author":"MB O'Connell","year":"2005","unstructured":"O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118:778\u2013781","journal-title":"Am J Med"},{"key":"5206_CR17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","volume":"93","author":"AK Nehra","year":"2018","unstructured":"Nehra AK, Alexander JA, Loftus CG, Nehra V (2018) Proton pump inhibitors: review of emerging concerns. Mayo Clin Proc 93:240\u2013246","journal-title":"Mayo Clin Proc"},{"key":"5206_CR18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1389200219666171207125351","volume":"19","author":"A Corsonello","year":"2018","unstructured":"Corsonello A, Lattanzio F, Bustacchini S, Garasto S, Cozza A, Schepisi R, Lenci F, Luciani F, Maggio MG, Ticinesi A, Butto V, Tagliaferri S, Corica F (2018) Adverse events of proton pump inhibitors: potential mechanisms. Curr Drug Metab 19:142\u2013154","journal-title":"Curr Drug Metab"},{"key":"5206_CR19","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/jbmr.108","volume":"25","author":"MJ Wright","year":"2010","unstructured":"Wright MJ, Sullivan RR, Gaffney-Stomberg E, Caseria DM, O'Brien KO, Proctor DD, Simpson CA, Kerstetter JE, Insogna KL (2010) Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 25:2205\u20132211","journal-title":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"},{"key":"5206_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/JOE-16-0017","volume":"230","author":"KM Aasarod","year":"2016","unstructured":"Aasarod KM, Ramezanzadehkoldeh M, Shabestari M et al (2016) Skeletal effects of a gastrin receptor antagonist in H+\/K+ATPase beta subunit KO mice. J Endocrinol 230:251\u2013262","journal-title":"J Endocrinol"},{"key":"5206_CR21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2265.2008.03194.x","volume":"69","author":"T Cundy","year":"2008","unstructured":"Cundy T, Dissanayake A (2008) Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol 69:338\u2013341","journal-title":"Clin Endocrinol"},{"key":"5206_CR22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14740338.2013.809062","volume":"12","author":"G Famularo","year":"2013","unstructured":"Famularo G, Gasbarrone L, Minisola G (2013) Hypomagnesemia and proton-pump inhibitors. Expert Opin Drug Saf 12:709\u2013716","journal-title":"Expert Opin Drug Saf"},{"key":"5206_CR23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10654-017-0242-2","volume":"32","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Whitehouse MR, Blom AW, Laukkanen JA (2017) Low serum magnesium levels are associated with increased risk of fractures: a long-term prospective cohort study. Eur J Epidemiol 32:593\u2013603","journal-title":"Eur J Epidemiol"},{"key":"5206_CR24","doi-asserted-by":"crossref","first-page":"413097","DOI":"10.1155\/2015\/413097","volume":"2015","author":"M Prause","year":"2015","unstructured":"Prause M, Seeliger C, Unger M, Rosado Balmayor E, van Griensven M, Haug AT (2015) Pantoprazole decreases cell viability and function of human osteoclasts in vitro. Mediat Inflamm 2015:413097","journal-title":"Mediat Inflamm"},{"key":"5206_CR25","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1111\/febs.12478","volume":"280","author":"J Costa-Rodrigues","year":"2013","unstructured":"Costa-Rodrigues J, Reis S, Teixeira S, Lopes S, Fernandes MH (2013) Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity. FEBS J 280:5052\u20135064","journal-title":"FEBS J"},{"key":"5206_CR26","first-page":"607","volume":"9","author":"Y Jo","year":"2015","unstructured":"Jo Y, Park E, Ahn SB, Jo YK, Son B, Kim SH, Park YS, Kim HJ (2015) A proton pump inhibitor's effect on bone metabolism mediated by osteoclast action in old age: a prospective randomized study. Gut and liver 9:607\u2013614","journal-title":"Gut and liver"},{"key":"5206_CR27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.injury.2014.05.005","volume":"45","author":"M Prause","year":"2014","unstructured":"Prause M, Seeliger C, Unger M, van Griensven M, Haug AT (2014) Pantoprazole increases cell viability and function of primary human osteoblasts in vitro. Injury 45:1156\u20131164","journal-title":"Injury"},{"key":"5206_CR28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3892\/mmr.2013.1327","volume":"7","author":"MK Joo","year":"2013","unstructured":"Joo MK, Park JJ, Lee BJ, Kim JH, Yeon JE, Kim JS, Byun KS, Bak YT (2013) The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. Molecular medicine reports 7:1267\u20131272","journal-title":"Molecular medicine reports"},{"key":"5206_CR29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11938-014-0030-y","volume":"12","author":"GI Leontiadis","year":"2014","unstructured":"Leontiadis GI, Moayyedi P (2014) Proton pump inhibitors and risk of bone fractures. Current treatment options in gastroenterology 12:414\u2013423","journal-title":"Current treatment options in gastroenterology"},{"key":"5206_CR30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/apt.14381","volume":"47","author":"LE Targownik","year":"2018","unstructured":"Targownik LE (2018) Editorial: Non-breaking news! High-dose PPIs likely do not cause fractures. Aliment Pharmacol Ther 47:137","journal-title":"Aliment Pharmacol Ther"},{"key":"5206_CR31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/phar.1410","volume":"34","author":"L Cea Soriano","year":"2014","unstructured":"Cea Soriano L, Ruigomez A, Johansson S, Garcia Rodriguez LA (2014) Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting. Pharmacotherapy 34:570\u2013581","journal-title":"Pharmacotherapy"},{"key":"5206_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrgastro.2011.272","volume":"9","author":"P Moayyedi","year":"2012","unstructured":"Moayyedi P, Leontiadis GI (2012) The risks of PPI therapy. Nat Rev Gastroenterol Hepatol 9:132\u2013139","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5206_CR33","unstructured":"Furu K (2008) Establishment of the nationwide Norwegian Prescription Database (NorPD)\u2013new opportunities for research in pharmacoepidemiology in Norway. Norsk Epidemiologi:129\u2013136"},{"key":"5206_CR34","doi-asserted-by":"crossref","unstructured":"Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, Bratberg G, Heggland J, Holmen J (2012) Cohort profile: the HUNT study, Norway. Int J Epidemiol","DOI":"10.1093\/ije\/dys095"},{"key":"5206_CR35","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44:734\u2013743","journal-title":"Bone"},{"key":"5206_CR36","doi-asserted-by":"crossref","unstructured":"Hoff M, Meyer HE, Skurtveit S, Langhammer A, Sogaard AJ, Syversen U, Dhainaut A, Skovlund E, Abrahamsen B, Schei B (2017) Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","DOI":"10.1007\/s00198-017-4134-9"},{"key":"5206_CR37","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bone.2009.11.024","volume":"46","author":"AB Gronskag","year":"2010","unstructured":"Gronskag AB, Forsmo S, Romundstad P, Langhammer A, Schei B (2010) Incidence and seasonal variation in hip fracture incidence among elderly women in Norway. The HUNT study. Bone 46:1294\u20131298","journal-title":"Bone"},{"key":"5206_CR38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11657-015-0235-2","volume":"10","author":"M Hoff","year":"2015","unstructured":"Hoff M, Skurtveit S, Meyer HE, Langhammer A, Sogaard AJ, Syversen U, Abrahamsen B, Schei B (2015) Use of anti-osteoporotic drugs in central Norway after a forearm fracture. Archives of osteoporosis 10:235","journal-title":"Archives of osteoporosis"},{"key":"5206_CR39","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.2015.5161","volume":"313","author":"MR Blum","year":"2015","unstructured":"Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD, Peeters RP, \u00c5svold BO, den Elzen W, Luben RN, Imaizumi M, Bremner AP, Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G, Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, J\u00fcni P, Aujesky D, Rodondi N, Thyroid Studies Collaboration (2015) Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313:2055\u20132065","journal-title":"JAMA"},{"key":"5206_CR40","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignement. Norway: Oslo. https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"5206_CR41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/sim.4780120902","volume":"12","author":"SE Vollset","year":"1993","unstructured":"Vollset SE (1993) Confidence intervals for a binomial proportion. Stat Med 12:809\u2013824","journal-title":"Stat Med"},{"key":"5206_CR42","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bone.2015.08.024","volume":"81","author":"MMC van der Hoorn","year":"2015","unstructured":"van der Hoorn MMC, Tett SE, de Vries OJ, Dobson AJ, Peeters G (2015) The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study. Bone 81:675\u2013682","journal-title":"Bone"},{"key":"5206_CR43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2011.03.026","volume":"160","author":"P Vestergaard","year":"2012","unstructured":"Vestergaard P, Steinberg TH, Schwarz P, Jorgensen NR (2012) Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture. Int J Cardiol 160:36\u201340","journal-title":"Int J Cardiol"},{"key":"5206_CR44","doi-asserted-by":"crossref","unstructured":"Dadwal G, Schulte-Huxel T, Kolb G (2019) Effect of antithrombotic drugs on bone health. Zeitschrift fur Gerontologie und Geriatrie","DOI":"10.1007\/s00391-019-01590-8"},{"key":"5206_CR45","first-page":"3710959","volume":"2017","author":"KY Chin","year":"2017","unstructured":"Chin KY (2017) A review on the relationship between aspirin and bone health. J Osteoporos 2017:3710959","journal-title":"J Osteoporos"},{"key":"5206_CR46","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1359\/jbmr.2003.18.10.1795","volume":"18","author":"LD Carbone","year":"2003","unstructured":"Carbone LD, Tylavsky FA, Cauley JA, Harris TB, Lang TF, Bauer DC, Barrow KD, Kritchevsky SB (2003) Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 18:1795\u20131802","journal-title":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"},{"key":"5206_CR47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijcard.2017.06.089","volume":"244","author":"TN Bonten","year":"2017","unstructured":"Bonten TN, de Mutsert R, Rosendaal FR, Jukema JW, van der Bom JG, de Jongh RT, den Heijer M (2017) Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general population. Int J Cardiol 244:298\u2013302","journal-title":"Int J Cardiol"},{"key":"5206_CR48","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE Levesque","year":"2010","unstructured":"Levesque LE, Hanley JA, Kezouh A, Suissa S (2010) Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. Bmj 340:b5087","journal-title":"Bmj"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05206-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:28:09Z","timestamp":1605572889000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05206-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5206"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05206-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MH, SS, HM, AD, AJS, AL, ES, SF, and BS have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}